TCN1作为牛皮的炎症调节剂:激活NF-κB通路和潜在的治疗点
Jian Huang1, Huanhuan Yu2, Xiuqing Yuan3
1Department of Dermatology, Guangdong College of Clinical Dermatology, Anhui Medical University, Hefei, Anhui Province, People's Republic of China; The Fifth School of Clinical Medicine, Anhui Medical University, Hefei, Anhui Province, People's Republic of China; Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong Province, People's Republic of China.
International immunopharmacology
|May 3, 2025
概括
在牛皮中,TCN1被上调,通过NF-κB通路驱动炎症和细胞周期变化. 这表明TCN1可能是牛皮的诊断生物标志物和治疗标.
科学领域:
- 皮肤病学和免疫学研究.
- 分子生物学和细胞信号传递.
背景情况:
- 牛皮是一种慢性炎症性皮肤疾病.
- 在牛皮病原发生过程中TCN1的作用尚不完全理解.
研究的目的:
- 研究TCN1在调节牛皮炎炎症和细胞循环中的作用.
- 阐明NF-κB通路在TCN1-介导作用中的参与.
主要方法:
- 牛皮皮肤转录组数据的生物信息分析.
- 在体外实验中使用HaCaT角质细胞刺激TNF-α和IL-17A.
- 通过siRNA和过度表达进行TCN1调制,然后进行qPCR,西式涂抹和免疫光.
- 使用BrdU-PI流细胞计进行细胞周期分析.
主要成果:
- 在牛皮病变中,TCN1表达升高,与疾病严重程度相关 (PASI评分).
- TCN1上调激活NF-κB通路,增加炎症介质并促进S相细胞周期进展.
- 生物治疗减少了TCN1的表达.
结论:
- TCN1通过调节炎症和细胞循环,在牛皮中发挥关键作用.
- TCN1是一种潜在的诊断生物标志物和牛皮的治疗标.
相关概念视频
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...


